Certified by Founder Lodge 
                                        
                                        CHV
 
                                                 United States  -  Boston, Massachusetts 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $30,000,000
                                            5 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            CHV (Catalyst Health Ventures) invests in transformative MedTech companies that are addressing global unmet healthcare needs and have the potential to become the new standard of care. Our the
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Instylla | 
                                                            August, 16 ,2023 | Unknown | $30,000,000 | 
   AtaCor Medical, Inc. | 
                                                            April, 25 ,2024 | Series C | $28,000,000 | 
   Brixton Biosciences | 
                                                            May, 15 ,2024 | Series B | $33,000,000 | 
   Venova Medical, Inc. | 
                                                            September, 05 ,2024 | Series B | $30,000,000 | 
   Esperto Medical | 
                                                            February, 21 ,2025 | Series A | 
                                                
  Instylla
  AtaCor Medical, Inc.
  Brixton Biosciences
  Venova Medical, Inc.
  Esperto Medical
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)